X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-09-01 | INCY | Swain Paula J | EVP, HR | S - Sale | $65.13 | -8,449 | 77,530 | -10% | -$550,283 | ||||||
2023-08-01 | INCY | Stein Steven H | EVP, Chief Medical Officer | S - Sale | $63.28 | -21,511 | 97,583 | -18% | -$1,361,216 | ||||||
D | 2023-01-31 | INCY | Pasquale Maria E | EVP, GC | S - Sale+OE | $84.06 | -802 | 68,524 | -1% | -$67,416 | |||||
D | 2023-01-30 | INCY | Pasquale Maria E | EVP, GC | S - Sale+OE | $84.74 | -60,024 | 68,524 | -47% | -$5,086,569 | |||||
D | 2023-01-26 | INCY | Iyengar Vijay K | EVP, GMAPPS | S - Sale+OE | $85.00 | -7,000 | 42,835 | -14% | -$595,000 | |||||
2023-01-26 | INCY | Dhanak Dashyant | EVP, Chief Scientific Officer | S - Sale | $85.00 | -2,419 | 53,263 | -4% | -$205,615 | ||||||
2023-01-04 | INCY | Stein Steven H | EVP, Chief Medical Officer | S - Sale | $79.78 | -28,399 | 109,021 | -21% | -$2,265,672 | ||||||
D | 2022-12-23 | INCY | Iyengar Vijay K | EVP, GMAPPS | S - Sale+OE | $80.80 | -17,324 | 37,855 | -31% | -$1,399,739 | |||||
2022-12-19 | INCY | Tray Thomas | Principal Accounting Officer | S - Sale | $82.16 | -1,223 | 16,606 | -7% | -$100,482 | ||||||
2022-07-22 | INCY | Tray Thomas | Principal Accounting Officer | S - Sale | $83.13 | -1,564 | 17,702 | -8% | -$130,015 | ||||||
2022-07-07 | INCY | Iyengar Vijay K | EVP, GMAPPS | S - Sale | $79.38 | -5,787 | 40,313 | -13% | -$459,372 | ||||||
2022-07-07 | INCY | Flannelly Barry P | EVP, GM US | S - Sale | $79.38 | -2,873 | 72,674 | -4% | -$228,059 | ||||||
D | 2022-04-08 | INCY | Flannelly Barry P | EVP, GM US | S - Sale+OE | $83.49 | -43,993 | 65,163 | -40% | -$3,672,887 | |||||
DM | 2022-03-08 | INCY | Baker Bros. Advisors LP | Dir, 10% | P - Purchase | $72.24 | +389,080 | 34,012,428 | +1% | +$28,107,770 | |||||
M | 2022-02-17 | INCY | Baker Bros. Advisors LP | Dir, 10% | P - Purchase | $67.96 | +525,804 | 33,632,977 | +2% | +$35,734,890 | |||||
2022-01-31 | INCY | Dickinson Jonathan Elliott | EVP, GM, Europe | S - Sale | $74.19 | -7,375 | 30,214 | -20% | -$547,151 | ||||||
D | 2022-01-07 | INCY | Swain Paula J | EVP, HR | S - Sale+OE | $73.31 | -10,870 | 72,371 | -13% | -$796,880 | |||||
D | 2022-01-03 | INCY | Trower Paul | Principal Accounting Officer | S - Sale+OE | $73.31 | -8,214 | 32,268 | -20% | -$602,168 | |||||
D | 2022-01-04 | INCY | Swain Paula J | EVP, HR | S - Sale+OE | $73.46 | -9,319 | 72,371 | -11% | -$684,574 | |||||
D | 2021-12-23 | INCY | Dixon Wendy L | Dir | S - Sale+OE | $22.05 | -20,000 | 17,259 | -54% | -$441,000 | |||||
M | 2021-12-15 | INCY | Baker Bros. Advisors LP | Dir, 10% | P - Purchase | $72.43 | +1,595,519 | 34,399,479 | +5% | +$115,558,900 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |